Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja [Yahoo! Finance]
Anixa Biosciences, Inc. (ANIX)
Last anixa biosciences, inc. earnings: 3/9 05:10 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
May 6, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced a podcast interview of Anixa Chairman and CEO Dr. Amit Kumar by oncologist Dr. Sanjay Juneja , with more than 500,000 followers through his media brand 'TheOncDoc.' The interview is broadly available on podcast platforms and can be viewed now on YouTube In the "Target: Cancer Podcast," Dr. Juneja interviews Dr. Kumar about 'The Vaccine That Could End Breast Cancer.' The doctors discuss the unique science behind Anixa's vaccine technology, which enables the immune system to destroy cancer cells at the earliest stage and prevent them from growing and spreading to surrounding tissues and structures. Commenting on the potential for Anixa's vaccines, Dr. Juneja stated, "It would be wonderful if we could do for cancer what we have done for infectious diseases." "It was a pleasure to join D
Show less
Read more
Impact Snapshot
Event Time:
ANIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIX alerts
High impacting Anixa Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ANIX
News
- Anixa expands cancer vaccine collaboration with Cleveland Clinic [Yahoo! Finance]Yahoo! Finance
- Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines [Yahoo! Finance]Yahoo! Finance
- Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer VaccinesPR Newswire
- Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay JunejaPR Newswire
- Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024PR Newswire
ANIX
Earnings
- 9/6/23 - Beat
ANIX
Analyst Actions
- 3/21/24 - HC Wainwright
ANIX
Sec Filings
- 5/8/24 - Form 8-K
- 5/3/24 - Form SC
- 5/2/24 - Form 4
- ANIX's page on the SEC website